Selvas Healthcare셀바스헬스케어
208370 · KOSDAQ · ₩208370 · 셀바스헬스케어
₩2,110▼ ₩70 (3.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 49.1% | 48.7% | 52.2% | 52.5% | 49.9% | 48.0% |
| Operating margin | 4.9% | −0.5% | 10.3% | 11.2% | 8.4% | 11.7% |
| Net margin | 27.4% | 12.6% | 9.9% | 17.3% | 9.6% | 8.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +2.8% | −2.8% | +6.3% | +7.7% | −4.8% | — |
| Operating income growth | +1,065.4% | −104.9% | −2.2% | +44.3% | −32.0% | — |
| Net income growth | +123.6% | +23.4% | −39.0% | +95.1% | +7.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 11.8% | 5.8% | 5.1% | 11.1% | 8.7% | 8.8% |
| Return on assets | −5.3% | 5.2% | 4.6% | 9.2% | 5.6% | 5.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 12.4% | 11.1% | 10.1% | 11.0% | 37.1% | 74.6% |
| Net debt to equity | −27.1% | −28.6% | −29.5% | −32.3% | 9.4% | −3.1% |
| Current ratio | 745.5% | 915.2% | 807.6% | 664.3% | 235.7% | 154.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Selvas Healthcare / 셀바스헬스케어 / 208370 / KRX:208370
Source: KRX statistical information